日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals

在居里研究所医院接受治疗的 HER2 阳性乳腺癌患者中,新辅助曲妥珠单抗-美坦新治疗后的疗效和毒性

De Moura, Alexandre; Gleizes, Orane; Cabel, Luc; Bethune-Volters, Anne; Bellesoeur, Audrey; Bello-Roufai, Diana; Cottu, Paul; Sebbag, Clara; Loirat, Delphine; Geiss, Romain; Pierga, Jean-Yves; Escalup, Laurence; Bidard, François Clément; Genevée, Thomas

Improving olaparib exposure to optimize adverse effects management

提高奥拉帕尼暴露量以优化不良反应管理

Sterlé, Marylise; Puszkiel, Alicja; Burlot, Chloé; Pereira, Eva; Bellesoeur, Audrey; De Percin, Sixtine; Beinse, Guillaume; Fumet, Jean-David; Favier, Laure; Niogret, Julie; Blanchet, Benoit; Royer, Bernard; Bengrine-Lefevre, Leïla; Schmitt, Antonin

Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients

癌症患者SARS-CoV-2感染的特征和结局

Basse, Clémence; Diakite, Sarah; Servois, Vincent; Frelaut, Maxime; Noret, Aurélien; Bellesoeur, Audrey; Moreau, Pauline; Massiani, Marie-Ange; Bouyer, Anne-Sophie; Vuagnat, Perrine; Malak, Sandra; Bidard, François-Clément; Vanjak, Dominique; Kriegel, Irène; Burnod, Alexis; Bilger, Geoffroy; Ramtohul, Toulsie; Dhonneur, Gilles; Bouleuc, Carole; Cassoux, Nathalie; Paoletti, Xavier; Bozec, Laurence; Cottu, Paul

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer

帕博西尼联合内分泌治疗在HR阳性、HER2阴性晚期乳腺癌中的真实世界疗效

Porte, B; Carton, M; Lerebours, F; Brain, E; Loirat, D; Haroun, L; Bellesoeur, A; Bach Hamba, S; Kirova, Y; Cottu, P

COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area

新冠肺炎在乳腺癌患者中的流行情况:巴黎居里研究所医院的一项队列研究

Vuagnat, Perrine; Frelaut, Maxime; Ramtohul, Toulsie; Basse, Clémence; Diakite, Sarah; Noret, Aurélien; Bellesoeur, Audrey; Servois, Vincent; Hequet, Delphine; Laas, Enora; Kirova, Youlia; Cabel, Luc; Pierga, Jean-Yves; Bozec, Laurence; Paoletti, Xavier; Cottu, Paul; Bidard, François-Clément

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

在CERTIM泛癌队列研究中,肿瘤炎症特征(TIS)与抗PD-1治疗获益相关。

Damotte, Diane; Warren, Sarah; Arrondeau, Jennifer; Boudou-Rouquette, Pascaline; Mansuet-Lupo, Audrey; Biton, Jérôme; Ouakrim, Hanane; Alifano, Marco; Gervais, Claire; Bellesoeur, Audrey; Kramkimel, Nora; Tlemsani, Camille; Burroni, Barbara; Duche, Angéline; Letourneur, Franck; Si, Han; Halpin, Rebecca; Creasy, Todd; Herbst, Ronald; Ren, Xing; Morel, Pascale; Cesano, Alessandra; Goldwasser, François; Leroy, Karen

Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?

真实世界中非小细胞肺癌患者接受纳武利尤单抗治疗是否存在暴露-反应关系?

Bellesoeur, Audrey; Ollier, Edouard; Allard, Marie; Hirsch, Laure; Boudou-Rouquette, Pascaline; Arrondeau, Jennifer; Thomas-Schoemann, Audrey; Tiako, Manuela; Khoudour, Nihel; Chapron, Jeanne; Giraud, Frédérique; Wislez, Marie; Damotte, Diane; Lupo, Audrey; Vidal, Michel; Alexandre, Jérôme; Goldwasser, François; Tod, Michel; Blanchet, Benoit

Choosing a career in oncology: results of a nationwide cross-sectional study

选择肿瘤学职业:一项全国性横断面研究的结果

Faivre, J C; Bibault, J E; Bellesoeur, A; Salleron, J; Wack, M; Biau, J; Cervellera, M; Janoray, G; Leroy, T; Lescut, N; Martin, V; Molina, S; Pichon, B; Teyssier, C; Thureau, S; Mazeron, J J; Roché, H; Culine, S

Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy

阿昔替尼在肾细胞癌治疗中的应用:设计、开发及治疗地位

Bellesoeur, Audrey; Carton, Edith; Alexandre, Jerome; Goldwasser, Francois; Huillard, Olivier